Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

Overview of attention for article published in Modern Pathology, November 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter: 1 X user

patent: 46 patents

Readers on

mendeley: 184 Mendeley

So far, Altmetric has seen 46 patents that reference this research output.

Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent…

Grant US-12685719-B2

United States of America

21 Jul 2026

Methods of treating castration-resistant prostate cancer with glucocorticoid receptor…

Grant US-12648951-B2

United States of America

09 Jun 2026

Concomitant administration of glucocorticoid receptor modulator relacorilant and…

Grant US-12589094-B2

United States of America

31 Mar 2026

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin…

Grant US-12514849-B2

United States of America

06 Jan 2026

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 42 additional patents.